Sarepta Therapeutics, Inc. SEC filings SRPT
Sarepta Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2026 | Sep 23, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 13F-HR | Filing | Aug 14, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 30, 2026 | — |
| 4 | Insider transaction | Jul 29, 2026 | Jul 28, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 28, 2026 |
| S-8 | Employee stock plan registration | Jul 28, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| S-8 | Employee stock plan registration | Jun 4, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 13F-HR | Filing | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 12, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Mar 2, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 13F-HR | Filing | Feb 13, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 19, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 144 | Notice of proposed sale | Dec 16, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Dec 11, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 9, 2025 | Dec 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2025 | Dec 7, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Nov 28, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 10, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 8, 2025 | — |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 29, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Aug 21, 2025 | Aug 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Aug 6, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 6, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 6, 2025 | Aug 5, 2025 |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 3 | Initial insider ownership | Aug 4, 2025 | Jul 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 25, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 25, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Jul 16, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 12, 2025 |
| 144 | Notice of proposed sale | Mar 12, 2025 | — |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| S-3ASR | Automatic shelf registration | Mar 3, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Feb 14, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 144 | Notice of proposed sale | Dec 12, 2024 | — |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 144 | Notice of proposed sale | Dec 5, 2024 | — |
| 4 | Insider transaction | Nov 29, 2024 | Nov 26, 2024 |
| 3 | Initial insider ownership | Nov 29, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 26, 2024 | Nov 24, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 4, 2024 |
| 4 | Insider transaction | Sep 3, 2024 | Aug 30, 2024 |
| 144 | Notice of proposed sale | Aug 30, 2024 | — |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| S-8 | Employee stock plan registration | Aug 7, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 8, 2024 | Jul 3, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 144 | Notice of proposed sale | Jun 25, 2024 | — |
| 144 | Notice of proposed sale | Jun 25, 2024 | — |
| 144 | Notice of proposed sale | Jun 24, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 7, 2024 | — |
| 4 | Insider transaction | May 6, 2024 | May 2, 2024 |
| 3 | Initial insider ownership | May 6, 2024 | Apr 24, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 6, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| 4 | Insider transaction | Mar 11, 2024 | Mar 8, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 144 | Notice of proposed sale | Mar 11, 2024 | — |
| 144 | Notice of proposed sale | Mar 8, 2024 | — |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 5, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SRPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 873303
- Former names
- Sarepta Therapeutics, Inc. (until Nov 5, 2026); AVI BIOPHARMA INC (until Jul 12, 2012); ANTIVIRALS INC (until May 12, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.